GAA expansion size and age at onset of Friedreich’s ataxia
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
More than 95% of patients with Friedreich ataxia (FA) are homozygous for GAA trinucleotide repeat expansions within intron 1 of the FRDA gene located on chromosome 9q13.1 A clear relation between GAA expansion size and phenotype variability has been found, and the size of the smaller GAA expansion (GAA1 allele) is the major determining factor for the variability in age at onset and rate of disease progression.2-7⇓⇓⇓⇓⇓ Conversely, the role of the larger GAA expansion (GAA2 allele) in age at onset has not been well established. We have assessed the predictive value of GAA1 and GAA2 sizes in regard to age at onset of the disease.
Methods.
We selected a group of 40 patients homozygous for GAA expansion on the first intron of the FRDA gene, which was determined as described previously.1 Age at onset was defined as the age at which the first neurologic symptom was …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Fabricio Ferreira de Oliveira and Dr. Alan Cronemberger Andrade
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Brief Communications
Homozygotes and heterozygotes for ciliary neurotrophic factor null alleles do not show earlier onset of Huntington's diseaseD. C. Rubinsztein, J. Leggo, M. Chiano et al.Neurology, September 01, 1997 -
Article
Refining the phenotype of Unverricht-Lundborg disease (EPM1)A population-wide Finnish studyJelena Hyppönen, Marja Äikiä, Tarja Joensuu et al.Neurology, March 13, 2015 -
Articles
Determinants of disability and quality of life in mild to moderate Parkinson diseaseD. Muslimović, B. Post, J. D. Speelman et al.Neurology, June 02, 2008 -
Article
Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosisErnst-Wilhelm Radue, Frederik Barkhof, Ludwig Kappos et al.Neurology, January 28, 2015